A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders - Summary - MDSpire

A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders

  • By

  • Louisa Leone

  • Tighe J. Kiernan

  • Satoshi Kuwabara

  • Michael Barnett

  • Emma Devenney

  • Rebekah M. Ahmed

  • Cindy Shin-Yi Lin

  • June 18, 2026

  • 0 min

Share

Objective:

To synthesize current evidence on the relationship between diabetes mellitus (DM) and ten clinically important neurological disorders.

Approach:
    Key Findings:
    • DM is implicated as a modifier of risk, phenotype, and prognosis across various neurological disorders.
    • Diabetes-related peripheral neuropathy affects approximately 50% of diagnosed individuals.
    • DM is associated with increased risk of Alzheimer’s disease, Parkinson’s disease, and inflammatory peripheral neuropathies.
    • A neuroprotective role of DM has been suggested in amyotrophic lateral sclerosis.
    • Mechanisms linking DM to neurological disorders include insulin resistance, inflammation, and disrupted energy homeostasis.
    Interpretation:

    Understanding the interplay between metabolic dysfunction, neurodegeneration, and neuro-immune pathways is crucial for the relationship between DM and neurological diseases.

    Limitations:
    • Limited early detection and disease-modifying therapies for many neurological syndromes.
    • The complexity of diabetes-associated neurobiology necessitates a comparative framework.
    • More comprehensive studies are needed to fully understand the complexities of diabetes-associated neurobiology.
    Conclusion:

    Understanding the relationship between DM and neurological disorders may inform prevention strategies and therapeutic interventions, emphasizing the mechanisms involved.

Original Source(s)

Related Content